Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 55
Updated:1/1/2014
Start Date:July 2012
Contact:Mike Andino
Email:Mike.Andino@ppdi.com
Phone:+1 855-714-0086

Use our guide to learn which trials are right for you!

The purpose of this study is to determine whether RPC1063 is effective in the treatment of
relapsing multiple sclerosis (RMS).


Inclusion Criteria:

- Multiple sclerosis as diagnosed by the revised 2010 McDonald criteria

- EDSS score between 0 and 5.0 at baseline

Exclusion Criteria:

- Secondary or primary progressive multiple sclerosis
We found this trial at
10
sites
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Akron, OH
Click here to add this to my saved trials
?
mi
from
Berkeley, CA
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Fresno, CA
Click here to add this to my saved trials
?
mi
from
Raliegh, NC
Click here to add this to my saved trials
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Weston, FL
Click here to add this to my saved trials